Coenzyme Q10 treatment improves the tolerance of the senescent myocardium to pacing stress in the rat

Cardiovascular Research

Volumn 40, Issue 1, 1998, Pages 165-173

  Rowland, Michael A ^d   Nagley, Phillip ^b   Linnane, Anthony W ^c   Rosenfeldt, Franklin L ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c Ctr for Molec Biol and Medicine   (Australia)

^d PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

Aging; Cardiovascular surgery; Contractile function; Energy metabolism; Mitochondria

Indexed keywords

UBIDECARENONE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; UBIQUINONE;

AGING; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR SURGERY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENERGY METABOLISM; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART PACING; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN; TREATMENT OUTCOME; ANALYSIS OF VARIANCE; ANIMAL; COMPARATIVE STUDY; FEMALE; HEART; HEART CONTRACTION; METABOLISM; OXYGEN CONSUMPTION; PERFUSION; PHYSIOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT;

ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; AGING; ANALYSIS OF VARIANCE; ANIMALS; CARDIAC PACING, ARTIFICIAL; FEMALE; HEART; MITOCHONDRIA, HEART; MYOCARDIAL CONTRACTION; OXYGEN CONSUMPTION; PERFUSION; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; UBIQUINONE;

EID: 0032176338     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00132-1     Document Type: Article

References (40)

1. [1] Edwards FH, Clark RE, Schwartz M. Coronary artery bypass grafting: The Society of Thoracic Surgeons National database experience. Ann Thorac Surg 1994;57:12-19.
2. [2] Chung M, Bosner M, McKenzie J, et al. Prognosis of patients ≥70 years of age with non-Q-wave acute myocardial infarction compared with younger patients with similar infarcts and with patients ≥70 years of age with Q-wave acute myocardial infarction. Am J Cardiol 1995;75:18-22.
3. [3] Stone G, Grines C, Browne K, et al. Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the primary angioplasty in myocardial infarction (PAMI) trial. J Am Coll Cardiol 1995;25:370-377.
4. [4] Lindsay Jr. J, Reddy V, Pinnow E, et al. Morbidity and mortality rates in elderly patients undergoing percutaneous coronary transluminal angioplasty. Am Heart J 1994;128:697-702.
5. [5] Richardson M, Pitney M, Gibbons F, et al. Short and long term results of coronary angioplasty in patients over 75 years. Aust New Zealand J Med 1994;24:55-60.
6. [6] Acinapura AJ, Rose DM, Cunningham JNJ, et al. Coronary artery bypass in septuagenarians: analysis of mortality and morbidity. Circulation 1988;78:I179-I184.
7. [7] Shah V, Rosenfeldt F, Parkin G, et al. Cardiac surgery in the very elderly. Med J Aust 1994;160:332-334.
8. [8] Christakis G, Ivanov J, Weisel R, et al. The changing pattern of coronary artery bypass surgery. Circulation 1989;80:151-161.
9. [9] Edwards F, Taylor A, Thompson L, et al. Current status of coronary artery operation in septuagenarians. Ann Thorac Surg 1991;52:265-269.
10. [10] Misare B, Krukenkamp I, Levitsky S. Age-dependent sensitivity to unprotected cardiac ischemia: the senescent myocardium. J Thorac Cardiovasc Surg 1992;103:60-65.
11. [11] McCully JD, Tsukube T, Ataka K, et al. Myocardial cytosolic calcium accumulation during ischemia/reperfusion: the effects of aging and cardioplegia. J Card Surg 1994;9(Suppl):449-452.
12. [12] Ozawa T. Mechanism of somatic mitochondrial DNA mutations associated with age and diseases. Biochim Biophys Acta 1995;1271:177.
13. [13] Lakatta E, Yin F. Myocardial aging: functional alterations and related cellular mechanisms. Am J Physiol 1982;242:H927-H941.
14. [14] Linnane A, Marzuki S, Ozawa T, et al. Mitochondrial DNA mutations as an important contributor to aging and degenerative diseases. Lancet 1989;i:642-645.
15. [15] Shoffner J, Wallace D. Oxidative phosphorylation diseases. In: Scriver C, Beaudet A, Sly W, Valle D, editors. The metabolic and molecular basis of inherited diseases. New York: McGraw-Hill, 1995:1535.
16. [16] Nagley P, Zhang C, Martinus RD et al. Mitochondrial DNA mutation and human aging: Molecular biology, bioenergetics and redox therapy. In: Mauro S, Wallace DC, editors. Mitochondrial DNA in human pathology. New York: Raven Press, 1993:137.
17. 10 Drug Surveillance Investigators. Clin Invest 1993;71(Suppl 8):S145-S149.
18. [18] Linnane AW, Zhang C, Baumer A, et al. Mitochondrial DNA mutation and the aging process: bioenergy and pharmacological intervention. Mutat Res 1992;275:195-208.
19. 31P-NMR study. Neurology 1989;39:399-403.
20. [20] Linnane A, Degli Esposti M, Generowicz M, et al. The universality of bioenergetic disease and amelioration with redox therapy. Biochim Biophys Acta 1995;1271:191-194.
21. [21] Taegtmeyer H, Hems R, Krebs H. Utilization of energy-providing substrates in the isolated working rat heart. Biochem J 1980;186:701-711.
22. [22] Beyer RE, Starnes JW Coenzyme Q and myocardial function in aging and exercise. In: Stone HL, Weglicki WB, editors. Pathobiology of cardiovascular injury. Boston: Martinus Nijhoff, 1985:489-511.
23. [23] Munsch C, Rosenfeldt F, O'Halloran K, et al. The effect of orotic acid on the response of the recently infarcted rat heart to hypothermic cardioplegia. Eur J Cardiothorac Surg 1991;5:82-93.
24. [24] Kannengiesser GJ, Opie LH, Werff TJVD. Impaired cardiac work and oxygen uptake after reperfusion of regionally ischemic myocardium. J Mol Cell Cardiol 1979;11:197-207.
25. 2 in human plasma. J Appl Physiol 1969;26:56-60.
26. [26] Gutmann I, Wahlefeld AW L-(+)-Lactate determination with lactate dehydrogenase and NAD. In: Bergmeyer HU, editor. Methods of enzymatic analysis. Vol 3. New York: Academic Press, 1974:1464-1468.
27. [27] Lamprecht W, Stein P, Heinz F et al. Creatine phosphate. Determination with creatine kinase, hexokinase and glucose-6-phosphate dehydrogenase. In: Bergmeyer HU, editor. Methods of enzymatic analysis. Vol 3. New York: Academic Press, 1974:1777-1785.
28. [28] Gregg DE. Effect of coronary perfusion pressure and coronary flow on oxygen usage in the myocardium. Circ Res 1963;13:497-500.
29. + channel activity and tone in rat vascular tissue. Exp Physiol 1995;80:825-834.
30. [30] Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?. Lancet 1994;344:721-724.
31. [31] Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993;90:7915-7922.
32. [32] Sohal RS, Arnold LA, Sohal BH. Age-related changes in antioxidant enzymes and pro-oxidant generation in tissues of the rat with special reference in two insect species. Free Radic Biol Med 1990;9(6):495-500.
33. [33] Papa S. Mitochondrial oxidative phosphorylation changes in the lifespan. Molecular aspects and physiopathological implications. Biochim Biophys Acta 1996;1276:87-105.
34. [34] Kovalenko SA, Kopsidas G, Kelso JM, et al. Deltoid human muscle mtDNA is extensively rearranged in old subjects. Biochem Biophys Res Commun 1997;232:147-152.
35. [35] Hayakawa M, Sugiyama S, Hattori K, et al. Age-associated damage in mitochondrial DNA in human hearts. Mol Cell Biochem 1993;119:95-103.
36. [36] Crane F, Sun I, Clark M, et al. Transplasma-membrane redox systems in growth and development. Biochim Biophys Acta 1985;811:233.
37. [37] Sun IL, Sun EE, Crane FL, et al. Evidence for coenzyme Q function in transplasma membrane electron transport. Biochem Biophys Res Commun 1990;172:979-984.
38. 10 putatively acting through plasma membrane oxidase. Biochem Mol Biol Int 1993;31:997-1005.
39. [39] Lenaz G, Fato R, Castelluccio C, et al. The function of coenzyme Q in mitochondria. Clin Invest 1993;71:S66-S70.
40. [40] Chen X, Presser R, Simonetti S, et al. Rearranged mitochondrial genomes are present in human oocytes. Am J Hum Genet 1995;57:239.